Pharmaceutical Lipids Market

Report Overview

According to the deep-dive market assessment study conducted by Growth Plus Reports, the global pharmaceutical lipids market was valued at US$ 5.84 billion in 2021 and is expected to register a revenue CAGR of 6.64 % to reach US$ 10.41 billion in 2030.

Market Fundamentals 

Lipids are organic compounds that are insoluble in water. Fats and oils are common names for lipids. Oils are liquid at room temperature, whereas fats remain solid. One of the most crucial elements of both natural foods & several manufactured chemicals and emulsions are lipids. The components of bioactive lipids depend on their contribution to health. Lipids are only soluble in an organic, non-polar solvent. These molecules, which are present in meals like oil, butter, whole milk, cheese, fried dishes, as well as some red meats, can be secreted by the liver in the human body. Triacylglycerols are the most prevalent (TAGs) lipids. 

[4545454]

Market Dynamics

The pharmaceutical lipids industry is quickly expanding all around the world. For the administration of pharmaceuticals, lipids are frequently utilized as fillers, binders, lubricants, solubilizers, emulsifiers, and emollients. Major factors expected to expand the global pharmaceutical lipids market revenue include the flourishing cosmetic industry around the world and the rising demand from the beauty industry for lipid solutions as ingredients. Major companies are making significant investments in product development, and their strategy of growing the business through product launches and acquisitions is expected to accelerate the revenue growth of the pharmaceutical lipids market globally.

However, fatty acid and other raw material price increases across the board serve as a hindrance to the global pharmaceutical lipids market revenue expansion.

Market Ecosystem

The global pharmaceutical lipids market has been analyzed from four perspectives: product, source, form, application, end-user, and region.

Pharmaceutical Lipids Market by Product 

[2345424]

Based on the product the global pharmaceutical lipids market is segmented into triglycerides, phospholipids, sphingolipids, cholesterol, fatty acids, and others. 

The triglycerides segment accounts for the largest revenue in the global market. Its large revenue share can be attributed to the rising demand for medium-chain triglycerides, and long-chain triglycerides to be used in efficient beverages and dietary supplements, for their derivatives. Since triglyceride lipids constitute a significant source of energy, they are widely used in a variety of functional foods and beverages. They can be utilized in many galenic forms, such as a basis for suppositories, a solubilizer, an emulsifier, a substrate or lubricant in tablets, and soft gel capsules. Thus, various industrial utilization of the triglyceride’s products is the most important factor to fuel the global pharmaceutical lipids market. 

Pharmaceutical Lipids Market by Source

Based on sources, the global pharmaceutical lipid market is segmented into three classes viz. synthetic, semi-synthetic, and natural sources. 

The semi-synthetic lipid source segment accounts for the largest revenue CAGR. Fundamentally, there are two precursors of lipids i.e., natural and synthetic. Due to stability issues and the potential for viral or protein contamination, natural sources are not suitable for clinical purposes. Glycerol or glycerol-3-phosphocholine (GPC) produced from a plant or animal source can be used to make synthetic lipids. Since a portion of the molecule comes from a natural source, the latter is occasionally referred to as semi-synthetic lipid. On the other hand, animal-derived products do not have any advantages over synthetic lipids, despite the regulatory concerns. These are intrinsically less stable, and the synthetic alternative typically costs the same as or less than the product obtained from tissue. 

Semi-synthetic polymers are frequently used in cosmetic products such as creams, shampoos, lotions, and gels as gelling agents, bioadhesives, thickening, and stabilizing agents. Compared to natural gelling agents, they are less susceptible to microbial contamination. Thus, the expanding cosmetic industry is also contributing to market revenue growth. 

Pharmaceutical Lipids Market by Form

Based on forms, the global pharmaceutical lipids market is segmented into liquid, semi-solid, and solid. 

Semi-solid lipid segment accounts for the largest revenue share in terms of market. This high revenue growth is due to their semi-solid texture and colloidal particle size which are the most recent generation of lipid nanoparticles acting as potential systems in nano-cosmeceuticals. Furthermore, as semi-solid consistency can be achieved in a single stage, it makes production simpler and eliminates the need for additional excipients with the rising revenue growth of this segment. Additionally, it has been observed that despite the high lipid content, a gel-like structure can be formed while the semi-solid solution maintains the colloidal size and viscoelastic capabilities. Hence, with easy accessibility, simpler productivity, and advantages over liquid and solid-state lipids, the global market of semi-solid lipids is expanding in terms of revenue share. 

Pharmaceutical Lipids Market by Application 

Based on applications, the global pharmaceutical lipids market is segmented into, conventional lipid-based drug delivery systems, self-emulsifying drug delivery systems, self-micro-emulsifying drug delivery systems, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, and others. 

The conventional lipid-based drug delivery system segment dominates the market with the largest revenue share. The primary objective of this formulation is to enhance the bioavailability of lipid-based medicines. One of the cutting-edge technologies created to solve issues like the solubility and bioavailability of poorly water-soluble pharmaceuticals is lipid-based drug delivery systems. Lipid-based formulations can be customized to satisfy a variety of product needs, including those imposed by the indication of the condition, the method of administration, cost considerations, product stability, toxicity, and efficacy, driving h revenue growth of this segment. It is a smart marketing strategy to use these formulations to produce drugs for topical, oral, pulmonary, or parenteral administration. Additionally, it has been demonstrated that lipid-based formulations can alter the biodistribution of a drug's toxicity by shifting it away from sensitive organs.

Pharmaceutical Lipids Market by End-user

Based on the end-user, the global pharmaceutical lipids market is segmented into biopharmaceutical companies, contract research organizations, academics, and research institutes. 

The biopharmaceutical company segment accounts for the largest revenue share in terms of market. Due to the expanding use in drug development and numerous other pharmaceutical applications, lipids are expected to rise significantly in terms of revenue share. This segment was one of the most essential components used in the invention of COVID-19 vaccines in 2021. In the pharmaceutical business, these are recognized as an essential excipients for the creation of a vast majority of dosage forms. Growing health concerns and the importance of medications are expected to increase the demand for pharmaceuticals, driving the revenue growth of this segment soon.

Pharmaceutical Lipids Market by Region

Based on the region, the global pharmaceutical lipids industry is expanded over North America, Europe, Asia Pacific, and the Rest of the World. 

North America accounts for the largest revenue CAGR, because of a greater understanding of severe precautions and the consumption of immune-boosting foods among North Americans. As a result, functional foods and dietary supplements are now an integral part of daily diets in North America. In the coming years, the rising dietary supplement and functional food consumption in North America is expected to fuel the market revenue for lipids.

Competitive Landscape

The prominent players operating the global pharmaceutical lipids market are: 

• BASF SE
• Croda International Plc
• CordenPharma
• NOF (Nippon Oil & Fats) Corporation
• Cayman Chemical Company
• Lipoid GmbH
• Nippon Fine Chemical Co. Ltd.
• Dishman Group
• Gattefossé
• IOI Oleo GmbH
• Stepan Company
• Evonik Industries AG

Strategic Development

• In May 2021, Merck has introduced a new, high-purity synthetic cholesterol product to fulfill the rising demand for lipids, a crucial component of mRNA-based vaccines and treatments.
• In September 2021, the agreement for the distribution of lipids has been expanded by ABITEC corporation and DKSH.

Frequently Asked Questions About This Report